Cell attachment and mouse virulence of echovirus 9 correlate with an RGD motif in the capsid protein VP1

Virology

Volumn 233, Issue 1, 1997, Pages 149-156

  Zimmermann, Holger ^a   Eggers, Hans J ^a   Nelsen Salz, Birgit ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ADHESION; ECHO VIRUS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; VIRUS CAPSID; VIRUS INFECTION; VIRUS RECOMBINANT; VIRUS VIRULENCE;

ECHOVIRUS; HUMAN ECHOVIRUS 9; MIRIDAE;

EID: 0030805087     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8601     Document Type: Article

References (27)

1. v3. J. Virol. 69:1995;2664-2666.
2. Bültmann B., Eggers H. J., Galle J., Haferkamp O. Age dependance of paralysis induced by echovirus type 9 in infant mice. J. Infect. Dis. 147:1983;999-1005.
3. Caggana M., Chan P., Ramsingh A. Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J. Virol. 67:1993;4797-4803.
4. Chang K. H., Auvinen P., Hyypiä T., Stanway G. The nucleotide sequence of coxsackievirus A9: Implications for receptor binding and enterovirus classification. J. Gen. Virol. 70:1989;3269-3280.
5. Eggers H. J., Sabin A. B. Factors determining pathogenicity of variants of ECHO 9 virus for newborn mice. J. Exp. Med. 110:1959;951-967.
6. Evans D. M. A., Dunn G., Minor P. D., Schild G. C., Cann A. J., Stanway G., Almond J. W., Currey K., Maizel J. V. Jr. Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome. Nature. 314:1985;548-550.
7. Fox G., Parry N. R., Barnett P. V., McGinn B., Rowlands D. J., Brown F. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid). J. Gen. Virol. 70:1989;625-637.
8. Fu J., Stein S., Rosenstein L., Bodwell T., Routbort M., Semler B., Roos R. Neurovirulence determinants of genetically engineered Theilers viruses. Proc. Natl. Acad. Sci. USA. 87:1990;4125-4129.
9. Hughes P. J., Horsnell C., Hyypiä T., Stanway G. The coxsackievirus A9 RGD motif is not essential for virus viability. J. Virol. 69:1995;8035-8040.
10. Hynes R. O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell. 69:1992;11-25.
11. Kriegler M. Gene Transfer and Expression - A Laboratory Manual. 1990;Freeman, New York.
12. Melnick J. L. Enteroviruses: Polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. Virology. 1996;Raven Press, New York. p. 655-712.
13. Morens D. M., Pallansch M. A., Moore M. Polioviruses and other enteroviruses. Belshe R. B. Textbook of Human Virology. 1991;427-497 Mosby Year Book, St. Louis.
14. Ramos-Alvarez M., Sabin A. B. Characteristics of poliomyelitis and other enteric viruses recovered in tissue culture from healthy American children. Proc. Soc. Exp. Biol. Med. 7:1954;655-661.
15. Ramsingh A. I., Collins D. A point mutation in the VP4 coding sequences of coxsackievirus B4 influences virulence. J. Virol. 69:1995;7278-7281.
16. Ren R., Moss E. G., Racaniello V. R. Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J. Virol. 65:1991;1377-1382.
17. Roivainen M., Hyypiä T., Piirainen L., Kalkkinen N., Stanway G., Hovi T. RGD-dependent entry of coxsackievirus A9 into host cells and its bypass after cleavage of VP1 protein by intestinal proteases. J. Virol. 65:1991;4735-4740.
18. v3. Virology. 203:1994;357-365.
19. Rosenwirth B., Eggers H. J. Structure and replication of echovirus type 12. 1. Analysis of the polypeptides and RNA of echovirus 12 particles. Eur. J. Biochem. 92:1978;53-60.
20. Rueckert R. R. Picornaviridae: Fields B. N., Knipe D. M., Howley P. M. Virology. 1996;609-654 Raven Press, New York.
21. Ruoslahti E., Pierschbacher M. D. New perspectives in cell adhesion: RGD and integrins. Science. 2:1987;491-497.
22. Stanway G., Kalkinnen N., Roivainen M., Ghazi F., Khan M., Smyth M., Meurman O., Hyypiä T. Molecular and biological characteristics of echovirus 22, a representative of a new picornavirus group. J. Virol. 68:1994;8232-8238.
23. Tu Z., Chapman N. M., Hufnagel G., Tracy S., Romero J. R., Barry W. H., Zhao L., Currey K., Shapiro B. The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5′ nontranslated region. J. Virol. 69:1995;4607-4618.
24. van Kuppefeld F. J. M., Galama J. M. D., Zoll J., van den Hurk P. J. J. C., Melchers W. J. G. Coxsackie B3 virus protein 2B contains a cationic amphipathic helix that is required for viral RNA replication. J. Virol. 70:1996;3876-3886.
25. Westrop G. D., Wareham K. A., Evans D. M. A., Dunn G., Minor P. D., Magrath D. I., Taffs F., Marsden S., Skinner M. A., Schild G. C., Almond J. W. Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J. Virol. 63:1989;1338-1344.
26. Zimmermann H., Eggers H. J., Nelsen-Salz B. Molecular cloning and sequence determination of the complete genome of the virulent echovirus 9 strain Barty. Virus Genes. 12:1996;149-154.
27. Zimmermann H., Eggers H. J., Zimmermann A., Kraus W., Nelsen-Salz B. Complete nucleotide sequence and biological properties of an infectious clone of prototype echovirus 9. Virus Res. 39:1995;311-319.